Art

J-GLOBAL ID：201402220557358864   Reference number：14A0552325

Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels

血清インスリンおよびペプチドYYレベルと血漿グルコース,コレシストキニン,グレリン,およびオベスタチンレベルに対するミグリトール,ビルダグリプチン,またはこれらの併用の効果

Author (8)： AOKI Kazutaka (Dep. of Biostatistics and Epidemiology, Yokohama City Univ. Hospital, Yokohama 236-0004, JPN) ,  AOKI Kazutaka (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN) ,  KAMIYAMA Hiroshi (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN) ,  MASUDA Kiyomi (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN) ,  KAMIKO Kazunari (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN) ,  NOGUCHI Yoshihiko (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN) ,  TAJIMA Kazuki (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN) ,  TERAUCHI Yasuo (Dep. of Endocrinology and Metabolism, Yokohama City Univ. Graduate School of Medicine, Yokohama 236-0004, JPN)
Material： Endocrine Journal  (Endocr J)
Volume： 61  Issue： 3  Page： 249-256 (J-STAGE)  Publication year： 2014 
JST Material Number： F0625A  ISSN： 0918-8959  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： drug therapy ,...
Semi thesaurus term： insulin

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0552325&from=J-GLOBAL&jstjournalNo=F0625A") }}

JST classification (2)： Drugs acting on metabolism in general  (GW13010F) ,  Other hormones of verterbrates  (EB08070K)

Substance index (3)： Glucose ,  Vildagliptin ,  Miglitol

Reference (35)：

• 1. Aoki K, Kato H, Terauchi Y (2007) Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men. Endocr J 54: 1009-1014.
• 2. Aoki K, Ito Y, Saito K, Shirakawa J, Togashi Y, et al. (2009) Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance. Diabetes Res Clin Pract 83: e31-32.
• 3. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, et al. (2002) STOP-NIDDM Trail Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial: Lancet 359: 2072-2077.
• 4. Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, et al. (2009) Voglibose Ph-3 Study Group: Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet 373: 1607-1614.
• 5. Narita T, Katsuura Y, Sato T, Hosoba M, Fujita H, et al. (2009) Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients. Diabet Med 26: 187-188.

Terms in the title (10)： 血清 ,  インスリン ,  ペプチドYY ,  血漿 ,  グルコース ,  コレシストキニン ,  グレリン ,  ミグリトール ,  ビルダグリプチン ,  併用